total solution of novel coronavirus 2019-ncov nucleic acid
TRANSCRIPT
Total Solution of Novel Coronavirus 2019-nCoV Nucleic Acid Detection
NMPA CERTIFICATE
Total Solution of Novel Coronavirus 2019-nCoV Nucleic Acid Detection
Solution1
Sampling
Nucleic Acid Extraction
Real Time PCR Amplification
· Highly Sensitive· Fully Automatic
Quick Nucleic Acid Detection Solution (Based on One-Step method)
Free of Nucleic Acid Extraction
· Rapid· Simple· Economical
Solution2
Automatic Nucleic Acid Extraction & Detection Solution
Real Time PCR Amplification
Fast Sample Release· Automatic Nucleic Acid Extraction System (Extractor & Kits)· 10min for extraction
· No Extractor· Only 30s operation to obtain nucleic acid
Uni-medica provides a high-throughput and rapid solution for screening and detecting COVID-19 during medical observation and in suspected population. It includes:
· Disposable Virus Sampling Kits.· Automatic Nucleic Acid Extraction System( Extractor & Kits).· Real Time PCR Amplification System.
Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab, N)
Nucleic Acid Detection Kits
ORF1ab gene
N gene
InternalControl
Advantage
High Accuracy
The product has been approved by the state drug administration and obtained NMPA and CE certification. The kit has been verified by 600+ clinical samples and used in more
than 100 hospitals and Centers for Disease Control and Prevention;
High Sensitivity
Limit of detection is 200 copies/ml;
Internal Control
The whole process is monitored by internal control;
Flexibility
Compatible with multiple brands of Real Time PCR systems;
Rapid Reaction Time
~1.5 hours.
Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab, N, E)
ORF1ab gene
N gene
InternalControl
E gene
Multiplex Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab/Influenza A/Influenza B)
ORF1ab gene
Influenza A
InternalControl
Influenza B
In autumn and winter, it is very important to differential diagnosis influenza and COVID-19 to provide
patients with appropriate treatment. The kit provided by Uni-medica can simultaneously detect the
novel coronavirus 2019-nCoV (ORF1ab), influenza A and influenza B in one tube.
Advantage
High Accuracy
The product has been used in more than 100 hospitals and Centers for Disease Control and Prevention;
High Sensitivity
Limit of detection is 200 copies/ml;
Internal Control
The whole process is monitored by internal control;
Flexibility
Compatible with multiple brands of Real Time PCR systems;
Rapid Reaction Time
~1.5 hours;
High Efficiency
One detection can distinguish influenza A, influenza B and novel coronavirus
2019-nCoV;
High Specificity
No cross reaction with other pathogens, such as SARS-CoV, MERS-CoV, CoV-HKU1,
CoV-229E, CoV-NL63, etc.
Classify patients to avoid
cross infection
Detect COVID-19/FluA/FluB in one tube
Full-component Freeze-drying Technology
Freeze-Dried Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab, N)
And a series of freeze-dried products……
Freeze-drying Technology
Transport and Store at Room Temperature
Greatly Reduce Transportation Costs
Room temperature storageNo need low temperature storage, fully release cold storage space;
1Room temperature transportation Reduce transportation costs;
2
Zero lossAvoid loss of high viscosity components, such as enzyme;
3High convenienceOne-Step: Freeze-dried RT-PCR Mix are prepackaged in 8-strip tubes, only need to add nucleic acid;
4
High accuracyFreeze-dried RT-PCR Mix, avoid repeated freeze-thaw;
5High thermostability37℃ and 55℃ properties are confirmd.
6
Automatic Nucleic Acid Extraction System
Automatic NucleicAcid Extractor
Nucleic AcidExtraction Reagent
High recovery rate of magnetic beads: > 99%;
High capacity of nucleic Acid: >90%;
Rapid: purification of 1~32 samples in one run in 10 minutes;
Open system: nucleic acid extraction reagents and nucleic acid extractor are both open.
1
2
4
Sample Release Reagent
Classic Medium
Pre-loading Plate
Magnetic Bar Sleeve
3
Nucleic acid release reagent
RNA protectant
· To obtain nucleic acid only by one-step operation in 30s.
· Free of nucleic acid extraction.
Simple operation, Rapid processing;
No need to buy any nucleic acid extractors.
Real Time Fluorescence Quantitative PCR System (MA6000)
Products
Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab, N)
DescriptionSpecs
50 tests/kit Analytes: ORF1ab, N gene and Internal control
Multiplex Real Time PCR Kit for Novel Coronavirus 2019-nCoV(ORF1ab)/Influenza A/Influenza B
50 tests/kitAnalytes: Novel coronavirus 2019-nCoV (ORF1ab), Influenza A, Influenza B and Internal control
Disposable Virus Sampling Tube
Automatic Nucleic Acid Extractor (Magnetic Bead Adsorption Method)
ITEM No.
R030
R033
R029
/
50 pcs/kit
M32
PP fiber swabs and Virus sampling tube
Flux: 1~32 samplesExtraction time: 10 minutes
Sample Release Reagent R031 100 tests/kitLysing the virus samples and Release the nucleic acid
Nucleic Acid Extraction Reagent
64 tests/kit, 96 tests/kit, 384 tests/kit, 100 tests/kit,300 tests/kit, 1000 tests/kit
Saliva samples, Sputum, Nasopharyngeal swabs, Oropharyngeal swabs, Bronchoalveolar lavage fluid(BALF), Blood serum and plasma
R024R025
Real Time Fluorescence Quantitative PCR System /MA6000 Flux: 1~96 samples
Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab,N,E)
50 tests/kit Analytes: ORF1ab,N,E gene and Internal control
R034
Flux: 1~96 samples;
6-zone independent temperature control + edge
thermal compensation technology;
5 colors (can be upgraded to 8-color fluorescence);
High sensitivity: low copy samples can be
effectively detected.
SHENZHEN UNI-MEDICA TECHNOLOGY CO., LTDAddress: Block 6th, Liuxian Culture Park of Liuxiandong Village, Nanshan District,
Shenzhen, Guangdong Province, P. R. China
Telephone: 0086-755-86505501
E-mail: [email protected]
UNI-MEDICA
Shenzhen Uni-medica Technology Co., Ltd (Uni-medica) is a national high-tech enterprise. It has established cooperation and jointly performed a number of scientific research projects with the Hong Kong University of Science and Technology, Shenzhen University and Chinese Academy of Sciences. Uni-medica was also selected as one of the top 100 new Chinese innovative enterprises. The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R&D and industrialization of molecular diagnostic products aiming at prevention and control of infectious diseases and genetic diseases. Uni-medica provides total solution of accurate diagnosis of infectious diseases and genetic diseases based on multi-omics technologies, including multiplex PCR, NGS technology and flow cytometry. Uni-medica is qualified by ISO 13485 and NMPA quality control system. The pathogen molecular detection products are daily used in hundreds of hospitals, Centers for Disease Control and Prevention and Quarantine Laboratories throughout the country, providing strong support for prevention and control of infectious diseases.